Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by davgro on Nov 15, 2022 11:32am

Rare Group Photo

Stutters, Dumpster and Stocking celebrating ATE cash burn.  Looking good boys !!!

User image
Comment by Forestview on Nov 15, 2022 12:50pm
Yep, they complain there's no progress, but then don't want the company to spend money either to make progress. A hilarious bunch of clowns.   Reality is, the ATE team is making significant progress, drug development takes time, and requires some changes in stratgy based on new information discovered in the scientific process.  
Comment by MrMugsy on Nov 15, 2022 4:23pm
Cash burn is in the right place. Modified formula is what makes acute faster acting and safer. Modified formula is also what makes chronic as safe as possible - work with it from here. Pre-op and intra-op are now also possible targets. Acute adoption is sitting at 30-50% ... better than I thought they'd say. Market potential bigger than ever. Now waiting on animal studies - pills - acute plan  ...more  
Comment by davgro on Nov 15, 2022 4:25pm
Are they not one and the same ??  lol
Comment by Inthepez on Nov 15, 2022 2:18pm
The retard behind all these aliases knows what he's doing despite being exposed multiple times including Czechcashings lol. All they do is spread FUD with superficial "analysis".
Comment by Duster340 on Nov 15, 2022 3:01pm
you just called davgro a retard  LMFAO
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities